subject who be pregnant will not be eligible to take part in the study a levetiracetam and lamotrigine be classify a pregnancy category c drug and may pose risk to the fetus woman of childbearing potential will have a urine pregnancy test prior to participation in the study the urine pregnancy test will be repeat at the final study visit subject with epilepsy who be of childbearing potential must use acceptable method of birth control during the study to be continue until one month after discontinuation of the study drug if a subject do become pregnant during this time period she must notify the investigator 